SEC Filing Summary: The Beauty Health Company (SKIN)
Business Context and Reporting Period
This Form 8-K, dated November 12, 2024, is a current report filed by The Beauty Health Company (formerly Skinhealth Systems Inc.). The filing announces the release of financial results for the quarter ended September 30, 2024. The company operates on the Nasdaq Capital Market under the ticker symbol SKIN.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the body of this 8-K document.
Material Changes
No specific material changes versus the prior comparable period are detailed in this filing. The document serves solely to notify investors of the issuance of the press release and the upcoming conference call regarding the Q3 2024 results.
Guidance, Outlook, and Management Commentary
- Non-GAAP Information: The company will present non-GAAP financial information in its press release and conference call, with a reconciliation to GAAP results provided in Exhibit 99.1.
- Disclosure Policy: The company states it discloses material non-public information through SEC filings, press releases, conference calls, and its investor relations website.
- Legal Disclaimer: Information furnished under Item 2.02, including the press release, is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual Q3 2024 revenue, net income, and cash flow figures.
- Examine the GAAP to non-GAAP reconciliation provided in the press release to understand adjusted metrics.
- Verify the company's current liquidity position and debt obligations as detailed in the full financial statements referenced in the press release.
- Check the investor relations website for the transcript of the conference call for management commentary on future outlook.